Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US.

Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT.

Drug Healthc Patient Saf. 2011;3:47-52. doi: 10.2147/DHPS.S23665. Epub 2011 Sep 8.

2.

Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study.

Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA.

J Allergy Clin Immunol. 2012 Aug;130(2):368-75. doi: 10.1016/j.jaci.2012.04.035. Epub 2012 Jun 12.

PMID:
22698520
3.

The relationship between antidepressant medication use and rate of suicide.

Gibbons RD, Hur K, Bhaumik DK, Mann JJ.

Arch Gen Psychiatry. 2005 Feb;62(2):165-72.

PMID:
15699293
4.

Association between leukotriene-modifying agents and suicide: what is the evidence?

Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD.

Drug Saf. 2011 Jul 1;34(7):533-44. doi: 10.2165/11587260-000000000-00000. Review.

PMID:
21663330
5.

The relationship between antidepressant prescription rates and rate of early adolescent suicide.

Gibbons RD, Hur K, Bhaumik DK, Mann JJ.

Am J Psychiatry. 2006 Nov;163(11):1898-904.

PMID:
17074941
6.

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ.

Am J Psychiatry. 2007 Sep;164(9):1356-63.

PMID:
17728420
7.

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.

Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB.

BMJ. 2014 Jun 18;348:g3596. doi: 10.1136/bmj.g3596.

8.

The Association Between Leukotriene-Modifying Agents and Suicidality: A Review of Literature.

Khalid F, Aftab A, Khatri S.

Psychosomatics. 2017 Aug 9. pii: S0033-3182(17)30181-0. doi: 10.1016/j.psym.2017.08.005. [Epub ahead of print] Review.

PMID:
28919375
9.
10.

Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis: an ecological study.

Woo JM, Gibbons RD, Qin P, Komarow H, Kim JB, Rogers CA, Mann JJ, Postolache TT.

J Clin Psychiatry. 2011 Oct;72(10):1423-8. doi: 10.4088/JCP.10m06765.

PMID:
22075102
11.

Antidepressant poisoning deaths in New Zealand for 2001.

Reith D, Fountain J, Tilyard M, McDowell R.

N Z Med J. 2003 Oct 24;116(1184):U646.

PMID:
14583804
12.

Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States.

Milane MS, Suchard MA, Wong ML, Licinio J.

PLoS Med. 2006 Jun;3(6):e190. Epub 2006 Jun 13.

13.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Olfson M, Marcus SC, Druss BG.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.

PMID:
18180433
14.

Association Between Gun Law Reforms and Intentional Firearm Deaths in Australia, 1979-2013.

Chapman S, Alpers P, Jones M.

JAMA. 2016 Jul 19;316(3):291-9. doi: 10.1001/jama.2016.8752. Erratum in: JAMA. 2016 Dec 6;316(21):2277.

PMID:
27332876
15.

Coprescribing and codispensing of cisapride and contraindicated drugs.

Jones JK, Fife D, Curkendall S, Goehring E Jr, Guo JJ, Shannon M.

JAMA. 2001 Oct 3;286(13):1607-9.

PMID:
11585484
16.

The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

Kurdyak PA, Juurlink DN, Mamdani MM.

Am J Public Health. 2007 Apr;97(4):750-4. Epub 2007 Feb 28.

17.

Epidemiology of major trauma and trauma deaths in Los Angeles County.

Demetriades D, Murray J, Sinz B, Myles D, Chan L, Sathyaragiswaran L, Noguchi T, Bongard FS, Cryer GH, Gaspard DJ.

J Am Coll Surg. 1998 Oct;187(4):373-83.

PMID:
9783783
18.

Gender and age differences in medications dispensed from a national chain drugstore.

Anthony M, Lee KY, Bertram CT, Abarca J, Rehfeld RA, Malone DC, Freeman M, Woosley RL.

J Womens Health (Larchmt). 2008 Jun;17(5):735-43. doi: 10.1089/jwh.2007.0731.

PMID:
18537477
19.

The impact of federal warnings on publically funded desmopressin utilization among children in Ontario.

Gomes T, Juurlink DN, Moore I, Maguire JL, Mamdani MM.

J Pediatr Urol. 2012 Jun;8(3):249-53. doi: 10.1016/j.jpurol.2011.06.001. Epub 2011 Jul 20.

PMID:
21767992
20.

Trends in opioid use and dosing among socio-economically disadvantaged patients.

Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM.

Open Med. 2011;5(1):e13-22. Epub 2011 Jan 25.

Supplemental Content

Support Center